GMM Pfaudler Ltd. Share Price

GMM Pfaudler hits a fresh new 52-week high

GMM Pfaudler Limited (

) gained 7.6% on September 18 and closed at ₹1,467 after touching a fresh 52-week high of ₹1,475. The stock has gained sharply from its June 2026 low of around ₹735, putting the recent price move firmly in focus from a technical perspective. Your view This is primarily a technical momentum setup. The stock has moved close to its 52-week high after a strong September rally. The level I would watch next is the ₹1,475 zone. Sustained trading above the recent high would keep momentum in focus, while failure to hold the breakout area would need monitoring. The next quarterly numbers will also be important because the current valuation leaves less room for disappointment. Disclosure: I do not hold any position or have any interest in GMM Pfaudler Limited as of the time of posting. Tags: Technical Views, Equity Research, Fundamental Views

See More

GMM Pfaudler gains 96% in 10 weeks, 9 closed green

GMM Pfaudler Limited rose 12% this week and 96% over 10 weeks. Weekly chart shows 9 green closes. See the ₹1,530 resistance and what to watch next. GMM Pfaudler Limited (NSE:

) ended at ₹1,454 on 18 September 2026, up 6.8% on the day and 12% for the week. On the weekly chart, 9 of the last 10 weeks closed green, adding about 96% in total. The small-cap engineering stock is now almost double from the 52-week low made in June 2026 about ₹735. The rally has business support. Q1 FY27 order backlog was a record ₹2,289 crore, up about 20% from last year. Defence, nuclear, mining and oil and gas made up 43% of Q1 orders. The trend is strong, but earnings quality needs a check. Q1 profit rose 118% to ₹22.1 crore, yet EBITDA fell 7% and margin was 10.1%. Forex gains and lower finance costs helped the profit. After a near 100% run, the stock needs better margins to hold these levels, so a pause is possible. Management indicated that much of the current order book carries 10–12 month execution cycles, supporting FY27 revenue visibility. What I am watching: ₹1,530 is the immediate resistance. A weekly close above it may keeps the uptrend intact. So the stock prices are positive on trend, cautious on chasing. Disclosure: Neither I nor my family members hold any position in the mentioned scrip. This content is shared solely for informational and educational purposes and should not be construed as investment advice or a recommendation to buy or sell.

See More

FY26: ₹2,194 Cr + 20% ORDER GROWTH + NDUSTRIAL

🚨 GMM PFAUDLER | FY26: ₹2,194 Cr ORDER BACKLOG + 20% ORDER GROWTH + MAJOR INDUSTRIAL DIVERSIFICATION GMM Pfaudler Limited delivered a year of execution, integration and business diversification in FY2025–26.

The company is gradually reducing its dependence on traditional Chemical & Pharma capex while expanding into Defence, Nuclear, Mining, Oil & Gas, Battery Technology and Food & Beverage. And the numbers show the transition. 📊 FY26 KEY NUMBERS 🔹 Consolidated Revenue: ₹3,524 Cr | +10% YoY 🔹 EBITDA: ₹403 Cr | +6% pre-exceptionals 🔹 Order Intake: ₹3,714 Cr | +20% YoY 🔹 Order Backlog: ₹2,194 Cr | +34% YoY 🔹 Standalone PAT: ₹59.32 Cr | +40% YoY 🔹 Free Cash Flow Conversion: >90% of EBITDA The company is simultaneously investing in: • Poland & India manufacturing hubs • Enterprise digitisation • AI-powered commercial review systems • R&D and product development • Testing and assembly infrastructure FY26 R&D expenditure reached ₹8.69 Cr. 🌍 GLOBAL COST RESTRUCTURING GMM Pfaudler is also restructuring higher-cost international operations. Germany restructuring resulted in ₹52.62 Cr of severance costs, while manufacturing is being increasingly aligned toward competitive hubs such as Poland and India. The objective is clear: Protect competitiveness while improving global manufacturing economics. ☀️ NEW ENERGY & TECHNOLOGY INVESTMENTS The company commissioned: 🔸 1 MW rooftop solar plant at Vatva 🔸 3.02 MW wind-solar hybrid captive project at Karamsad 🔸 NABL-accredited testing laboratory 🔸 Interseal Assembly Center in China These investments complement the broader operational transformation. 💰 GOVERNANCE & MANAGEMENT GMM Pfaudler appointed Gregory Gelhaus as Group CEO ! — Neha Gupta | SEBI Registered Research Analyst Registration No.: INH000016542 ⚠️ For educational and research purposes only. Not investment advice. Investors should conduct their own research and assess risks independently.

See More

GMM Pfaudler Shares Fall 1.4% After Strong Rally

GMM Pfaudler shares fell 1.38% to ₹1,329.25 on September 16 after an 83% rally. The company has announced a Group CFO transition effective November 4. GMM Pfaudler

shares declined 1.38% to ₹1,329.25 on September 16, 2026, after a sharp rally in recent months. The stock had gained around 83% from its earlier levels and touched a fresh 52-week high on September 15, before giving up some ground in Wednesday’s session. The latest development in focus is a change in the company’s senior finance leadership. Alexander Poempner has resigned as Group Chief Financial Officer and Key Managerial Personnel, with the transition scheduled to take effect on November 4, 2026. The Board has appointed Ankit Nayyar as the new Group CFO from the same date. Nayyar joined GMM Pfaudler as Deputy CFO in May 2026 and has nearly two decades of experience across pharmaceuticals, specialty chemicals, manufacturing and financial services. Poempner will continue with the company until December 31, 2026, to support an orderly handover. He has stated that he is leaving to pursue opportunities outside the GMM Pfaudler Group. Despite Wednesday’s decline, the stock remains up around 21% year-to-date, highlighting the strong price momentum seen during 2026. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes only. Investors must verify information before investing and consider their financial position & risk profile.

See More

GMM Pfaudler is a global engineering company .

Strong FY26 growth: Consolidated revenue reached approximately ₹3,624 Cr, up about 13.3% YoY. Strong order momentum: Order intake increased about 20%, while backlog was reported at around ₹2,146 Cr during FY26. India business performing well: India revenue grew around 12%, EBITDA about 24%, and India PAT around 40% in FY26. Global presence: The company has operations across multiple international markets, giving it access to global pharmaceutical and chemical capex. Strong niche positioning: GMM Pfaudler has established expertise in corrosion-resistant equipment and process technologies, creating entry barriers through technology, engineering capability and customer relationships. Q1 FY27 earnings acceleration: Q1 FY27 revenue was approximately ₹924 Cr, up 16.4% YoY, while PAT increased about 118% to ₹22 Cr. Financial Snapshot Metric FY25 FY26 Consolidated Revenue ₹3,199 Cr ₹3,624 Cr Revenue Growth — 13.3% EBITDA — ~₹403 Cr EBITDA Growth — ~11% Net Profit — ~₹58 Cr Order Intake — ~20% growth Order Backlog — ~₹2,146 Cr FY26 revenue and profit figures are based on reported consolidated results; different databases may show small differences depending on the reporting line used. 📌 Q1 FY27 Update Q1 FY27 was particularly strong: revenue ~₹924 Cr (+16.4% YoY) and PAT ~₹22 Cr (+117.7% YoY). This indicates significant earnings improvement compared with Q1 FY26. 📌 Key Takeaway GMM Pfaudler has a strong niche engineering franchise with improving growth and order momentum. FY26 showed double-digit revenue growth, while Q1 FY27 delivered a substantial improvement in profitability. The key things to monitor are order intake, backlog conversion, India vs international performance, EBITDA-margin expansion toward 15%+, working capital and acquisition execution.

See More

GMM Pfaudler Repays EUR 7M Debt via Subsidiary

GMM Pfaudler Ltd (GMMPFAUDLER) Debt Update: Company announces repayment of EUR 7 million debt through subsidiary GMM International, funded via internal accruals. The move supports debt reduction and enhances financial flexibility. 📊 Key Highlights Debt Repaid: EUR 7 million Subsidiary: GMM International Funding Source: Internal accruals Impact: Strengthens balance sheet, improves flexibility 📌 SWOT Analysis Strengths Strong global presence in glass‑lined equipment. Healthy cash flows enabling debt repayment. Diversified portfolio across pharma, chemicals, and food sectors. Weaknesses Exposure to currency fluctuations (EUR debt). High dependence on cyclical chemical/pharma demand. Opportunities Expansion in international markets. Rising demand for specialty process equipment. Potential for inorganic growth via acquisitions. Threats Competitive intensity from global peers. Regulatory risks in chemical and pharma industries. Raw material cost volatility. 🏭 Fundamentals Snapshot (FY26) Revenue: ~₹3,800 crore EBITDA Margin: ~15% PAT: ~₹320 crore Debt-to-Equity: ~0.4 (post repayment) Cash Position: Strong liquidity supporting growth This post is for informational purposes only and should not be construed as investment advice. Investors are advised to conduct their own research or consult financial advisors before making investment decisions.

See More